Brainsway Income After Taxes 2018-2024 | BWAY
Brainsway income after taxes from 2018 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
| Brainsway Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2024 | $3 |
| 2023 | $-4 |
| 2022 | $-13 |
| 2021 | $-6 |
| 2020 | $-5 |
| 2019 | $-10 |
| 2018 | $-6 |
| Brainsway Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $-2 |
| 2023-03-31 | $-2 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-2 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $0 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-3 |
| 2019-06-30 | $-3 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-1 |
| 2017-12-31 | |
| 2017-09-30 | $-2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.170B | $0.041B |
| BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel. | |||